# John Ballantyne, Angel Investor

Investor in Fargo, North Dakota

## About John Ballantyne, Angel Investor

John Ballantyne is an angel investor who has made at least 10 investments. His latest investment was in the Seed Round of VerImmune in September 2024. Verlmmune is an immuno-oncology company that is developing a first-class cancer therapy known as anti-tumor immune redirection.

His portfolio also includes GlucoTrack, Elegen, Thrixen, Cytonus Therapeutics, JURA Bio, CureLab Oncology, Myosana Therapeutics, CureLab Veterinary, and Kytopen.

John is a former CSO and VP of Aldervon, a biotechnology research company that is now part of Danaher.

## People

- **John Ballantyne**, Angel Investor

## Key Facts

- **Location:** Fargo, North Dakota
- **Investor Type:** Angel Investor

## Investment Industries

- Biotech
- Health and Wellness
- Medical/Healthcare

## How to Contact

Direct messaging and this investor's website are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/john-ballantyne-angel-investor
- More investors: [Biotech Investors in North Dakota](https://askforfunding.com/site/angel-investors/north-dakota/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
